About 1.6 million American women have breast biopsies each year. A biopsy obtaining actual tissue for microscopic evaluation is considered the gold standard for patient management and research outcomes.
Each year, about three million women in the United States will have an suspicious or abnormal pap test, according to the CDC. Following the abnormal results, women often undergo diagnostic testing a colposcopy or biopsy and if precancerous lesions are
A new type of genetic analysis of prostate cancers from biopsies seems to give a better assessment of prognosis than the standard methods. What implications might this have for the future of prostate cancer prognosis and follow-up?